Bank of New York Mellon
RBOT

Bank of New York Mellon’s Vicarious Surgical RBOT Stock Holding History

Bank of New York Mellon’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,328
Closed -$66.3K – 4237
2024
Q1 		$66.3K Buy
7,328
+1,028
+16% +$12.3K ﹤0.01% 4067
2023
Q4 		$69.3K Hold
6,300
– – ﹤0.01% 4136
2023
Q3 		$112K Buy
6,300
+72
+1% +$2.62K ﹤0.01% 4065
2023
Q2 		$342K Buy
6,228
+1,427
+30% +$90.9K ﹤0.01% 3771
2023
Q1 		$327K Sell
4,801
-11
-0.2% -$855 ﹤0.01% 3708
2022
Q4 		$292K Sell
4,812
-49
-1% -$4.55K ﹤0.01% 3805
2022
Q3 		$489K Buy
4,861
+527
+12% +$61.4K ﹤0.01% 3573
2022
Q2 		$383K Buy
4,334
+3,827
+755% +$468K ﹤0.01% 3751
2022
Q1 		$77K Buy
+507
New +$94.3K ﹤0.01% 4455

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.6B AUM 17.6% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon's RBOT Position: Q2 2024 in Review

Bank of New York Mellon sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 7,328 shares — an estimated $66.3K sold.

Bank of New York Mellon first reported a position in RBOT in Q1 2022 and held it in 9 quarters. The position peaked at $489K in Q3 2022. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • Bank of New York Mellon reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 7,328 Vicarious Surgical shares in Q2 2024, an estimated $66.3K.
  • Bank of New York Mellon first reported a position in Vicarious Surgical in Q1 2022 and held it in 9 quarters.
  • Bank of New York Mellon's Vicarious Surgical position peaked at $489K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.